Fiche publication
Date publication
août 2019
Journal
Cancers
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GHIRINGHELLI François
,
Dr REBE Cédric
Tous les auteurs :
Rébé C, Ghiringhelli F
Lien Pubmed
Résumé
Immune cells in the tumor microenvironment regulate cancer growth. Thus cancer progression is dependent on the activation or repression of transcription programs involved in the proliferation/activation of lymphoid and myeloid cells. One of the main transcription factors involved in many of these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on the role of STAT3 and its regulation, e.g. by phosphorylation or acetylation in immune cells and how it might impact immune cell function and tumor progression. Moreover, we will review the ability of STAT3 to regulate checkpoint inhibitors.
Mots clés
CD4+ T cells, CD8+ T cells, STAT3, cancer, immune check point., myeloid cells
Référence
Cancers (Basel). 2019 Aug 30;11(9):
